NDI 1168 - Cantech Pharma ImmuneBooster from Cantech Pharma, Inc.

From FDA U.S Food & Drug Administration Web Site-- The Food and Drug Administration (FDA) filed your notification that you submitted pursuant to 21 United States Code (U.S.C.) § 350b(a)(2) (section 413(a)(2) of the Federal Food, Drug, and Cosmetic Act (the Act)), on July 29, 2020. Your notification concerns a new dietary ingredient described as a combination of Enzolytics Pepsin from Porcine Liquid Supplement and Ascorbic Acid (Vitamin C) that you intend to market in a dietary supplement product under the trade name "Cantech Pharma ImmuneBooster." https://bit.ly/39W5kA5

According to your notification, the recommended conditions of use are: "[Take] 3mL/serving, 1 serving/day." The maximum daily serving of each ingredient in the dietary supplement is "12 mg pepsin and 150 mg ascorbic acid." Target populations: "All adults looking to boost their immune system." https://bit.ly/39W5kA5

Bassline Productions, Inc. (OTCMKTS: BSSP) The Company is now in process of seeking a merger or acquisition candidate. Effective October 9, 2017 the PSA Agreement with Canteck Pharma, inc. has been rescinded do inability to proceed with the license for Mexico that previously had focused on its immunotherapeutic based technology specific to Cancer indication. https://bit.ly/2VYcawP

Contact:

SmallCapZone

info@smallcapzone.com

Disclaimer:

All information contained herein as well as on the SmallCapZone.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of SmallCapZone.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. SmallCapZone.com has motivation by means of either self-marketing or SmallCapZone.com has been compensated by or for a company or companies discussed in this article. SmallCapZone.com has not been compensated for this article. You can easily lose money investing in highly speculative small cap/micro-cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When SmallCapZone.com is long shares it will sell those shares.

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE